Navigation Links
International Rett Syndrome Foundation awards $2M for cutting-edge Rett syndrome research
Date:10/1/2009

, PhD
Alfred I. DuPont Hospital for Children/Nemours Children's Clinic at the University of Delaware Preclinical testing of nonsense suppression in a rodent model of Rett syndrome

Dr. Schanen has previously developed mouse "knock-in" models of the R168X and R255X non-sense Rett syndrome mutations. The project will further generate colonies of the two knock-in mouse models and ultimately the new mouse models will be used to test a lead series of read-through compounds. The successful testing of these drugs could potentially result in a pharmacological reversal of Rett syndrome. This study would have an enormous impact upon the field and has clear implications for treatment of the disease.

Yi Eve Sun PhD, University of California at Los Angeles, David Geffen School of Medicine
The role of microRNA dysregulation in MeCP2-deficient neurons

The field of epigenetics has recently identified a set of small molecules called "micro-RNAs." These are thought to be critically important regulators that fine tune and modulate the function of different proteins and essential cellular processes. The aim of this project is to test the novel hypothesis that MeCP2 might regulate different sets of "micro-RNAs" in different neuronal subsets within the brain and which may have functional consequences as a whole. The proposal by Dr. Sun presents a clear set of experiments that will further our understanding of the basic mechanisms underlying Rett syndrome and could identify novel targets for therapeutic manipulation.

John Vincent PhD, The Centre for Addiction & Mental Health, University of Ottawa
Comparative Functional Studies Of The Two MeCP2 Isoforms, MeCP2_e1 and MeCP2_e2

This is a research proposal that aims to address the important question of which of the two common forms of MECP2 is most critical for brain development and function in the mouse. This is an interesting proposal that addresses a key as
'/>"/>

Contact: Dr. Antony Horton
212-459-2608
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. International conference on endothelin
2. International event brings worlds top cancer doctors to Queens
3. Forest Service to host 2nd International Conference on Forests and Water in a Changing Environment
4. EMBO pioneers pension plan for internationally mobile postdoctoral researchers
5. International conference on CO2 sequestration processes
6. International research team seeks to unravel flatworm regeneration
7. Fujitsu PalmSecure Certified Under International Common Criteria Evaluation Assurance Level 2
8. Journal of Vascular and Interventional Radiology increases impact, international reach
9. International team of students and scientists on month-long field course in Siberian Arctic
10. ESHRE launches international study of polar body screening
11. International collaboration by scientists culminates in novel ion channels database
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2014)... which is commonly used as a farm soil fertilizer, ... genes from the cows, gut bacteria. The findings, reported ... the American Society for Microbiology, hints that cow manure ... resistance genes that transfer to bacteria in the soils ... resistance (AR) genes have already been identified, but the ...
(Date:4/21/2014)... Dallas have received a federal grant to investigate ... of many everyday products might affect human health. ... and Dr. Rockford Draper, professor of molecular and ... from the National Institute of Environmental Health Sciences, ... track how multi-walled carbon nanotubes interact with human ...
(Date:4/21/2014)... Professor Lawrence Krauss was honored at the Academia ... to public understanding of science and for his ... The Academia Film Olomouc award for Outstanding Communication ... on April 19, in Olomouc, Czech Republic. , ... of science documentary films, and the largest such ...
Breaking Biology News(10 mins):Cow manure harbors diverse new antibiotic resistance genes 2Cow manure harbors diverse new antibiotic resistance genes 3Grant to fund research on possible cell contaminants 2Grant to fund research on possible cell contaminants 3Lawrence Krauss is honored at international festival of science documentary films 2Lawrence Krauss is honored at international festival of science documentary films 3
... (Edmonton) Two University of Alberta researchers have published a step ... harmful chemicals on commercial crops by developing plants that produce ... biologist Allen Good says the energy required to produce nitrogen ... a $100 billion a year. Good says that while they ...
... adelgid, has been marching north along the Appalachians, killing almost ... forests in Georgia, Tennessee, and Virginia. The pest recently arrived ... only extreme cold stops the adelgid. But now a ... "fungal microfactory" technology that promises to give forest managers and ...
... joint meeting of the International Ethological Conference (IEC) and ... more than 1,100 researchers from around the world for ... Included among the speakers will be one of ... head of the Department of Ethology at the Etvs ...
Cached Biology News:Forest fungus factory 2Behavior 2011 to draw global contingent of more than 1,100 animal researchers to IU next week 2
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: ... and commercializing innovative therapies addressing major unmet medical ... received the Notice of Allowance from the United ... self-delivering RNAi compounds (sd-rxRNA®), for the treatment of ...
(Date:1/14/2014)... UK (PRWEB) January 13, 2014 Bob ... with more than 20 years in the industry, has ... photonics . Hainsey will serve as the society’s Science ... Dr. Hainsey join SPIE as our Technology Strategist, further ...
(Date:1/14/2014)... Independent publisher Bitingduck Press, with offices in ... big ideas for 2014 in production and sales of ... produce high-quality, low-cost, DRM-free ebooks and to use the ... The first major development will be bookstore sales in ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... MONICA, Calif., Oct. 9 Aida,Pharmaceuticals, Inc. ... China,s,leading pharmaceutical companies, today announced that the ... sale of Etimicin,sulfate throughout China. Aida expects ... to increase noticeably as sales efforts are,pursued ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... company, today announced that it intends to ... Food and Drug Administration,(FDA) for its innovative, ... "After reviewing the data from our recently ...
... Pharmaceutical and biotech,companies reach much greater and sustained ... and marketing, balancing therapeutic,innovation with commercial focus in ... companies to break down the walls that have ... strengths of both,talented medical researchers and skillful marketers. ...
Cached Biology Technology:Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 2Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 2Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 3Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 4Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 5Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial 6Pharmaceutical Product Launch: Commercially Focused R&D Increases Drug's Market Potential 2